Investors can approximate the average market return by buying an index fund. But if you buy individual stocks, you can do both better or worse than that. That downside risk was realized by EDICO ...

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Investors can approximate the average market return by buying an index fund.

Highly Accurate, Low-Cost DRAGEN Genome Pipelines for Next-Generation Sequencing Analysis Now Readily Available in the Cloud Amazon EC2 F1 is a compute instance utilizing FPGAs that can be programed ...

San Diego’s Edico Genome, which makes a fast processing platform for next generation gene sequencing, said Tuesday that it has raised $22 million in a second round of venture capital funding led by ...

I am writing today to help inform people who are new to the stock market and want to begin learning the link between company’s fundamentals and stock market performance. EDICO Holdings Limited’s ...

DNA sequencer manufacturer Illumina has bought Edico Genome and its Dragen next-generation sequencing and data analysis platform. The terms of the deal were not disclosed. Dragen uses field ...

San Diego’s Illumina has acquired data processing technology start-up Edico Genome for $100 million to accelerate efforts to make genetic testing more widely accessible in everyday health care. The ...

Looks like a new single-drop-of-blood startup is is in the diagnostics arena: SalveoDx, a San Diego-based spinout of Domain Associates, just raised $2 million in equity. Pieter van Rooyen, a director ...

One of the biggest challenges facing providers who want to deploy precision medicine at the point of care is the changes it requires for physician workflow. A new partnership between Edico Genome and ...

San Diego-based Edico Genome has received $22 million in Series B financing to staff up and speed adoption of its Dragen genomic data platform. The round was led by new investor Dell Technologies ...

SAN DIEGO, May 6, 2015 /PRNewswire/ -- Edico Genome today announced that PerkinElmer, Inc. has purchased a DRAGEN™ Bio-IT processor to expedite the analysis of its customers' next-generation ...